CEP72-ROS1 : A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing-Reference-Cited by-同舟云学术

CEP72-ROS1 : A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next-generation sequencing

Author:

Zhu You-cai¹,Zhou Yue-fen²,Wang Wen-xian³^ORCID,Xu Chun-wei⁴^ORCID,Zhuang Wu⁵,Du Kai-qi¹,Chen Gang³

Affiliation:

1. Chest Disease Diagnosis and Treatment Center; Zhejiang Rongjun Hospital; Jiaxing China

2. Department of Oncology; Lishui Central Hospital, Lishui Hospital of Zhejiang University; Lishui China

3. Department of Chemotherapy; Zhejiang Cancer Hospital; Hangzhou China

4. Department of Pathology; Fujian Cancer Hospital, Fujian Medical University Cancer Hospital; Fuzhou China

5. Department of Medical Thoracic Oncology; Fujian Cancer Hospital, Fujian Medical University Cancer Hospital; Fuzhou China

Funder

National Clinical Key Specialty Construction Program

Science and Technology Planning Project of Zhejiang Province

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

Reference17 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献